Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Beijing Biostar Pharmaceuticals Co., Ltd. Class H ( (HK:2563) ) has issued an announcement.
Beijing Biostar Pharmaceuticals Co., Ltd. has announced the postponement of its board meeting originally scheduled for June 27, 2025, to June 30, 2025. The delay is due to the need for additional time to review and finalize the company’s consolidated annual results for the year ended December 31, 2024, which may impact the approval of the annual results and the consideration of a final dividend.
More about Beijing Biostar Pharmaceuticals Co., Ltd. Class H
Beijing Biostar Pharmaceuticals Co., Ltd. is a joint stock company incorporated in the People’s Republic of China, operating within the pharmaceutical industry. The company focuses on the development and distribution of pharmaceutical products.
Average Trading Volume: 357,800
Technical Sentiment Signal: Strong Sell
For an in-depth examination of 2563 stock, go to TipRanks’ Overview page.